ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 564,102 | $42,184,000 | 14.63% |
Fairmount Funds Management LLC | 387,400 | $28,970,000 | 9.55% |
Soleus Capital Management, L.P. | 318,275 | $23,801,000 | 2.38% |
Darwin Global Management, Ltd. | 166,190 | $12,428,000 | 1.90% |
Paradigm Biocapital Advisors LP | 75,507 | $5,646,000 | 1.61% |
ARMISTICE CAPITAL, LLC | 1,056,000 | $78,968,000 | 1.29% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 150,000 | $11,217,000 | 1.29% |
Portland Global Advisors LLC | 75,869 | $5,673,000 | 0.95% |
FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 | $117,691,000 | 0.59% |
Yorktown Management & Research Co Inc | 10,400 | $778,000 | 0.52% |